The global Low-dose Birth Control Pill market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Low-dose Birth Control Pill, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low-dose Birth Control Pill.
Report Scope
The Low-dose Birth Control Pill market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Low-dose Birth Control Pill market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low-dose Birth Control Pill manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
Market Segmentation
By Company
Lo Loestrin
Slynd
Balcoltra
Nextstellis
Taytulla
Bayer
Phexxi
Viatris
Tyblume
Twirla
Xulane
Alloy
Pfizer
Organon
Janssen
AbbVie
Teva Pharmaceutical
Segment by Type
Ethinyl Estradiol
Drospirenone
Levonorgestrel
Norethindrone
Others
Segment by Channel
Offline Sales
Online Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Low-dose Birth Control Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Low-dose Birth Control Pill in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Low-dose Birth Control Pill Market Overview
1.1 Product Overview and Scope of Low-dose Birth Control Pill
1.2 Low-dose Birth Control Pill Segment by Type
1.2.1 Global Low-dose Birth Control Pill Market Value Comparison by Type (2024-2030)
1.2.2 Ethinyl Estradiol
1.2.3 Drospirenone
1.2.4 Levonorgestrel
1.2.5 Norethindrone
1.2.6 Others
1.3 Low-dose Birth Control Pill Segment by Channel
1.3.1 Global Low-dose Birth Control Pill Market Value by Channel: (2024-2030)
1.3.2 Offline Sales
1.3.3 Online Sales
1.4 Global Low-dose Birth Control Pill Market Size Estimates and Forecasts
1.4.1 Global Low-dose Birth Control Pill Revenue 2019-2030
1.4.2 Global Low-dose Birth Control Pill Sales 2019-2030
1.4.3 Global Low-dose Birth Control Pill Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Low-dose Birth Control Pill Market Competition by Manufacturers
2.1 Global Low-dose Birth Control Pill Sales Market Share by Manufacturers (2019-2024)
2.2 Global Low-dose Birth Control Pill Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Low-dose Birth Control Pill Average Price by Manufacturers (2019-2024)
2.4 Global Low-dose Birth Control Pill Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Low-dose Birth Control Pill, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Low-dose Birth Control Pill, Product Type & Application
2.7 Low-dose Birth Control Pill Market Competitive Situation and Trends
2.7.1 Low-dose Birth Control Pill Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Low-dose Birth Control Pill Players Market Share by Revenue
2.7.3 Global Low-dose Birth Control Pill Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Low-dose Birth Control Pill Retrospective Market Scenario by Region
3.1 Global Low-dose Birth Control Pill Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Low-dose Birth Control Pill Global Low-dose Birth Control Pill Sales by Region: 2019-2030
3.2.1 Global Low-dose Birth Control Pill Sales by Region: 2019-2024
3.2.2 Global Low-dose Birth Control Pill Sales by Region: 2025-2030
3.3 Global Low-dose Birth Control Pill Global Low-dose Birth Control Pill Revenue by Region: 2019-2030
3.3.1 Global Low-dose Birth Control Pill Revenue by Region: 2019-2024
3.3.2 Global Low-dose Birth Control Pill Revenue by Region: 2025-2030
3.4 North America Low-dose Birth Control Pill Market Facts & Figures by Country
3.4.1 North America Low-dose Birth Control Pill Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Low-dose Birth Control Pill Sales by Country (2019-2030)
3.4.3 North America Low-dose Birth Control Pill Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Low-dose Birth Control Pill Market Facts & Figures by Country
3.5.1 Europe Low-dose Birth Control Pill Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Low-dose Birth Control Pill Sales by Country (2019-2030)
3.5.3 Europe Low-dose Birth Control Pill Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Low-dose Birth Control Pill Market Facts & Figures by Country
3.6.1 Asia Pacific Low-dose Birth Control Pill Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Low-dose Birth Control Pill Sales by Country (2019-2030)
3.6.3 Asia Pacific Low-dose Birth Control Pill Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Low-dose Birth Control Pill Market Facts & Figures by Country
3.7.1 Latin America Low-dose Birth Control Pill Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Low-dose Birth Control Pill Sales by Country (2019-2030)
3.7.3 Latin America Low-dose Birth Control Pill Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Low-dose Birth Control Pill Market Facts & Figures by Country
3.8.1 Middle East and Africa Low-dose Birth Control Pill Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Low-dose Birth Control Pill Sales by Country (2019-2030)
3.8.3 Middle East and Africa Low-dose Birth Control Pill Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Low-dose Birth Control Pill Sales by Type (2019-2030)
4.1.1 Global Low-dose Birth Control Pill Sales by Type (2019-2024)
4.1.2 Global Low-dose Birth Control Pill Sales by Type (2025-2030)
4.1.3 Global Low-dose Birth Control Pill Sales Market Share by Type (2019-2030)
4.2 Global Low-dose Birth Control Pill Revenue by Type (2019-2030)
4.2.1 Global Low-dose Birth Control Pill Revenue by Type (2019-2024)
4.2.2 Global Low-dose Birth Control Pill Revenue by Type (2025-2030)
4.2.3 Global Low-dose Birth Control Pill Revenue Market Share by Type (2019-2030)
4.3 Global Low-dose Birth Control Pill Price by Type (2019-2030)
5 Segment by Channel
5.1 Global Low-dose Birth Control Pill Sales by Channel (2019-2030)
5.1.1 Global Low-dose Birth Control Pill Sales by Channel (2019-2024)
5.1.2 Global Low-dose Birth Control Pill Sales by Channel (2025-2030)
5.1.3 Global Low-dose Birth Control Pill Sales Market Share by Channel (2019-2030)
5.2 Global Low-dose Birth Control Pill Revenue by Channel (2019-2030)
5.2.1 Global Low-dose Birth Control Pill Revenue by Channel (2019-2024)
5.2.2 Global Low-dose Birth Control Pill Revenue by Channel (2025-2030)
5.2.3 Global Low-dose Birth Control Pill Revenue Market Share by Channel (2019-2030)
5.3 Global Low-dose Birth Control Pill Price by Channel (2019-2030)
6 Key Companies Profiled
6.1 Lo Loestrin
6.1.1 Lo Loestrin Corporation Information
6.1.2 Lo Loestrin Description and Business Overview
6.1.3 Lo Loestrin Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lo Loestrin Low-dose Birth Control Pill Product Portfolio
6.1.5 Lo Loestrin Recent Developments/Updates
6.2 Slynd
6.2.1 Slynd Corporation Information
6.2.2 Slynd Description and Business Overview
6.2.3 Slynd Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Slynd Low-dose Birth Control Pill Product Portfolio
6.2.5 Slynd Recent Developments/Updates
6.3 Balcoltra
6.3.1 Balcoltra Corporation Information
6.3.2 Balcoltra Description and Business Overview
6.3.3 Balcoltra Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Balcoltra Low-dose Birth Control Pill Product Portfolio
6.3.5 Balcoltra Recent Developments/Updates
6.4 Nextstellis
6.4.1 Nextstellis Corporation Information
6.4.2 Nextstellis Description and Business Overview
6.4.3 Nextstellis Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nextstellis Low-dose Birth Control Pill Product Portfolio
6.4.5 Nextstellis Recent Developments/Updates
6.5 Taytulla
6.5.1 Taytulla Corporation Information
6.5.2 Taytulla Description and Business Overview
6.5.3 Taytulla Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taytulla Low-dose Birth Control Pill Product Portfolio
6.5.5 Taytulla Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Low-dose Birth Control Pill Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Phexxi
6.6.1 Phexxi Corporation Information
6.6.2 Phexxi Description and Business Overview
6.6.3 Phexxi Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Phexxi Low-dose Birth Control Pill Product Portfolio
6.7.5 Phexxi Recent Developments/Updates
6.8 Viatris
6.8.1 Viatris Corporation Information
6.8.2 Viatris Description and Business Overview
6.8.3 Viatris Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Viatris Low-dose Birth Control Pill Product Portfolio
6.8.5 Viatris Recent Developments/Updates
6.9 Tyblume
6.9.1 Tyblume Corporation Information
6.9.2 Tyblume Description and Business Overview
6.9.3 Tyblume Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tyblume Low-dose Birth Control Pill Product Portfolio
6.9.5 Tyblume Recent Developments/Updates
6.10 Twirla
6.10.1 Twirla Corporation Information
6.10.2 Twirla Description and Business Overview
6.10.3 Twirla Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Twirla Low-dose Birth Control Pill Product Portfolio
6.10.5 Twirla Recent Developments/Updates
6.11 Xulane
6.11.1 Xulane Corporation Information
6.11.2 Xulane Low-dose Birth Control Pill Description and Business Overview
6.11.3 Xulane Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Xulane Low-dose Birth Control Pill Product Portfolio
6.11.5 Xulane Recent Developments/Updates
6.12 Alloy
6.12.1 Alloy Corporation Information
6.12.2 Alloy Low-dose Birth Control Pill Description and Business Overview
6.12.3 Alloy Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Alloy Low-dose Birth Control Pill Product Portfolio
6.12.5 Alloy Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Corporation Information
6.13.2 Pfizer Low-dose Birth Control Pill Description and Business Overview
6.13.3 Pfizer Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pfizer Low-dose Birth Control Pill Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
6.14 Organon
6.14.1 Organon Corporation Information
6.14.2 Organon Low-dose Birth Control Pill Description and Business Overview
6.14.3 Organon Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Organon Low-dose Birth Control Pill Product Portfolio
6.14.5 Organon Recent Developments/Updates
6.15 Janssen
6.15.1 Janssen Corporation Information
6.15.2 Janssen Low-dose Birth Control Pill Description and Business Overview
6.15.3 Janssen Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Janssen Low-dose Birth Control Pill Product Portfolio
6.15.5 Janssen Recent Developments/Updates
6.16 AbbVie
6.16.1 AbbVie Corporation Information
6.16.2 AbbVie Low-dose Birth Control Pill Description and Business Overview
6.16.3 AbbVie Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.16.4 AbbVie Low-dose Birth Control Pill Product Portfolio
6.16.5 AbbVie Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Low-dose Birth Control Pill Description and Business Overview
6.17.3 Teva Pharmaceutical Low-dose Birth Control Pill Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Teva Pharmaceutical Low-dose Birth Control Pill Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Low-dose Birth Control Pill Industry Chain Analysis
7.2 Low-dose Birth Control Pill Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Low-dose Birth Control Pill Production Mode & Process
7.4 Low-dose Birth Control Pill Sales and Marketing
7.4.1 Low-dose Birth Control Pill Sales Channels
7.4.2 Low-dose Birth Control Pill Distributors
7.5 Low-dose Birth Control Pill Customers
8 Low-dose Birth Control Pill Market Dynamics
8.1 Low-dose Birth Control Pill Industry Trends
8.2 Low-dose Birth Control Pill Market Drivers
8.3 Low-dose Birth Control Pill Market Challenges
8.4 Low-dose Birth Control Pill Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Lo Loestrin
Slynd
Balcoltra
Nextstellis
Taytulla
Bayer
Phexxi
Viatris
Tyblume
Twirla
Xulane
Alloy
Pfizer
Organon
Janssen
AbbVie
Teva Pharmaceutical
听
听
*If Applicable.